Log In
Print this Print this

Tarafenacin (formerly SVT-40776)

  Manage Alerts
Collapse Summary General Information
Company Laboratorios Salvat S.A.
DescriptionMuscarinic acetylcholine receptor M3 (CHRM3; HM3) antagonist
Molecular Target Muscarinic acetylcholine receptor M3 (CHRM3) (HM3)
Mechanism of ActionMuscarinic acetylcholine receptor M3 antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationIncontinence
Indication DetailsTreat overactive bladder (OAB)
Regulatory Designation
PartnerKwang Dong Pharmaceutical Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today